Filtros

Buscador
Año
Casas G, Rodenas-Alesina E, Limeres J, Badia-Molins C, Larranaga-Moreira JM, Mirelis JG, Navarrete-Navarro J, Martin-Jimenez J, Alcala-Lopez JE, Gonzalez-Carrillo J, Teis A, Soler-Fernandez R, Teixido-Tura G, Gutierrez-Garcia L, Fernandez-Alvarez P, Munoz-Cabello P, Barrabes JA, Tiron C, Palomino-Doza J, Garcia-Pinilla JM, Bayes-Genis A, Ripoll-Vera T, Jimenez-Jaimez J, Villacorta E, Gimeno-Blanes JR, Zorio E, Garcia-Pavia P, Barriales-Villa R, Guala A, Petersen SE, Ferreira-Gonzalez I, Rodriguez-Palomares JF. Left ventricular ejection fraction decline and cardiovascular events in suspected cardiomyopathy with excessive trabeculation: toward precision medicine. Rev Esp Cardiol (Engl Ed). 2025 Feb 5:S1885-5857(25)00044-1. doi: 10.1016/j.rec.2025.01.011. Online ahead of print. English, Spanish. PubMed PMID: 39920987.
AÑO: 2025; IF: 4.9
Lozano-Paredes D, Bote-Curiel L, Sabater-Molina M, Bielza C, Gimeno-Blanes JR, Munoz-Romero S, Gimeno-Blanes FJ, Larranaga P, Rojo-Alvarez JL. Discovering Genetic Variants in Hypertrophic Cardiomyopathy With Multiple Machine Learning Techniques. IEEE Trans Comput Biol Bioinform. 2025 Jul-Aug;22(4):1822-1835. doi: 10.1109/TCBBIO.2025.3572833. PubMed PMID: 40811331.
AÑO: 2025
Maron MS, Gimeno JR, Veselka J, Barriales-Villa R, Claggett BL, Coats CJ, Hegde SM, Januzzi JL, Kulac IJ, Masri A, Nassif ME, Spertus JA, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Wohltman A, Olivotto I; SEQUOIA-HCM Investigators. Efficacy of Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy and Mild Symptoms: Results from the SEQUIOA-HCM Trial. Eur Heart J. 2025 May 17:ehaf364. doi: 10.1093/eurheartj/ehaf364. Online ahead of print. PubMed PMID: 40380955.
AÑO: 2025; IF: 35.6
Salar-Alcaraz M., Peñafiel-Verdú P., Castro-García F.J., Pastor-Quirante F.A., Muñoz-Esparza C., López-Ayala J.M., Martínez-Sánchez J., Sánchez-Muñoz J.J., García-Alberola A., Sabater-Molina M., Gimeno-Blanes J.R. Electrocardiogram May Fail to Identify Proportion of High-Risk Individuals: Analysis of Series of 50 Sudden Death Cases. Cardiogenetics. March 2025. 15. 10.3390/cardiogenetics15010005
AÑO: 2025; IF: 0.9
Garcia-Pavia P, Palomares JFR, Sinagra G, Barriales-Villa R, Lakdawala NK, Gottlieb RL, Goldberg RI, Elliott P, Lee P, Li H, Angeli FS, Judge DP, MacRae CA; REALM-DCM Investigators. REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA-Related Dilated Cardiomyopathy. Circ Heart Fail. 2024 Jul;17(7):e011548. doi: 10.1161/CIRCHEARTFAILURE.123.011548. Epub 2024 Jul 9. PubMed PMID: 38979608; PubMed Central PMCID: PMC11244753.
AÑO: 2024; IF: 8.4